Provided by Tiger Trade Technology Pte. Ltd.

Anaptysbio Inc

49.73
+1.833.82%
Post-market: 50.000.2700+0.54%17:40 EST
Volume:501.40K
Turnover:25.08M
Market Cap:1.38B
PE:-17.29
High:51.74
Open:48.91
Low:48.57
Close:47.90
52wk High:52.47
52wk Low:12.21
Shares:27.69M
Float Shares:14.25M
Volume Ratio:1.06
T/O Rate:3.52%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.8757
EPS(LYR):-5.1170
ROE:-308.02%
ROA:-4.23%
PB:-46.81
PE(LYR):-9.72

Loading ...

Is It Time To Reassess AnaptysBio (ANAB) After A 198% One-Year Share Price Surge

Simply Wall St.
·
Feb 06

AnaptysBio kündigt Abspaltung von Biopharma-Geschäft und Royalty-Vermögenswerten bis Ende 2026 an

Reuters
·
Feb 06

AnaptysBio Is Maintained at Overweight by Barclays

Dow Jones
·
Jan 21

Barclays Sticks to Their Buy Rating for AnaptysBio (ANAB)

TIPRANKS
·
Jan 20

U.S. RESEARCH ROUNDUP-Alphabet, Micron Technology, Microsoft

Reuters
·
Jan 20

AnaptysBio Director Magda Marquet Reports Disposal of Common Shares

Reuters
·
Jan 17

What AnaptysBio (ANAB)'s Royalty Spin-Off Plan Means For Shareholders

Simply Wall St.
·
Jan 10

AnaptysBio Pushes Back Against Lawsuit Over Cancer Drug Jemperli Royalties

Benzinga_recent_news
·
Jan 10

UK Stocks-Factors to watch on January 9

Reuters
·
Jan 09

BRIEF-Anaptys Files Motion To Dismiss Tesaro'S Claim Of Anticipatory Breach Of Contract In Ongoing Litigation

Reuters
·
Jan 09

AnaptysBio Seeks Dismissal of Tesaro’s Breach Claim in Delaware Court

Reuters
·
Jan 09

Anaptys Files Motion to Dismiss Tesaro’s Claim of Anticipatory Breach of Contract in Ongoing Litigation Against Tesaro, a GSK Subsidiary

THOMSON REUTERS
·
Jan 09

AnaptysBio Inc - Trial in Anaptys and Tesaro/GSK Dispute Set for July 14-17, 2026

THOMSON REUTERS
·
Jan 09

AnaptysBio CFO Dennis Mulroy Reports Disposal of Common Shares

Reuters
·
Jan 09

UBS Upgrades AnaptysBio to Buy From Neutral, Adjusts Price Target to $70 From $20

MT Newswires Live
·
Jan 07

AnaptysBio to Split Biopharma Operations and Royalty Assets by 2026

Reuters
·
Jan 07

AnaptysBio CFO Dennis Mulroy Reports Sale of Common Shares

Reuters
·
Dec 24, 2025

AnaptysBio CFO Dennis Mulroy Reports Disposal of Common Shares

Reuters
·
Dec 19, 2025

AnaptysBio Is Maintained at Overweight by Barclays

Dow Jones
·
Dec 18, 2025

U.S. RESEARCH ROUNDUP-Airbnb, Garrett Motion, Range Resources

Reuters
·
Dec 17, 2025